Gilberto Rosa-Da

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Correction: Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Correction: Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Journal: Dermatology and therapy
Published: August 11, 2026

Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Journal: Dermatology and therapy
Published: March 06, 2026

Successful treatment of refractory cutaneous involvement of NXP2-positive dermatomyositis with intravenous immunoglobulins.

Successful treatment of refractory cutaneous involvement of NXP2-positive dermatomyositis with intravenous immunoglobulins.

Journal: European journal of dermatology : EJD
Published: September 18, 2025

Long-Standing Vascular Lesions of the Ear and Periauricular Area: Answer.

Long-Standing Vascular Lesions of the Ear and Periauricular Area: Answer.

Journal: The American Journal of dermatopathology
Published: August 19, 2025

Long-Standing Vascular Lesions of the Ear and Periauricular Area: Challenge.

Long-Standing Vascular Lesions of the Ear and Periauricular Area: Challenge.

Journal: The American Journal of dermatopathology
Published: June 26, 2025

Cheilitis Granulomatosa of Miescher.

Cheilitis Granulomatosa of Miescher.

Journal: Journal of cutaneous medicine and surgery
Published: May 24, 2025

Use of biologics in pediatric-onset hidradenitis suppurativa: a case series.

Use of biologics in pediatric-onset hidradenitis suppurativa: a case series.

Journal: Anais brasileiros de dermatologia
Published: January 24, 2025

Concurrent therapy with dupilumab and infliximab for atopic dermatitis and Crohn's disease.

Concurrent therapy with dupilumab and infliximab for atopic dermatitis and Crohn's disease.

Journal: Italian journal of dermatology and venereology
Published: May 28, 2024

Patients with laboratory criteria of anti-phospholipid syndrome and 'non-criteria' manifestations: a multicenter cohort.

Patients with laboratory criteria of anti-phospholipid syndrome and 'non-criteria' manifestations: a multicenter cohort.

Journal: Scandinavian journal of rheumatology
Published: June 20, 2022

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review.

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review.

Journal: Frontiers in immunology
Published: June 12, 2022

Predictive value of the adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: a longitudinal study.

Predictive value of the adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: a longitudinal study.

Journal: Rheumatology (Oxford, England)
Published: May 12, 2022

Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines.

Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines.

Journal: Expert review of hematology
Published: April 28, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026